A detailed history of Pfs Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pfs Partners, LLC holds 325 shares of LLY stock, worth $249,522. This represents 0.16% of its overall portfolio holdings.

Number of Shares
325
Previous 375 13.33%
Holding current value
$249,522
Previous $340 Million 15.18%
% of portfolio
0.16%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$772.14 - $960.02 $38,607 - $48,001
-50 Reduced 13.33%
325 $288 Million
Q1 2024

Apr 15, 2024

SELL
$592.2 - $792.28 $14,805 - $19,807
-25 Reduced 6.25%
375 $292 Million
Q2 2023

Nov 30, 2023

BUY
$350.74 - $468.98 $8,768 - $11,724
25 Added 6.67%
400 $188 Million
Q2 2022

Nov 30, 2023

SELL
$278.73 - $327.27 $6,968 - $8,181
-25 Reduced 6.25%
375 $122 Million
Q4 2021

Nov 30, 2023

BUY
$224.85 - $279.04 $89,940 - $111,616
400 New
400 $110 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pfs Partners, LLC Portfolio

Follow Pfs Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfs Partners, LLC with notifications on news.